European Healthtech startup funding raised during H2 2021.
In H2 2021, 370 European Healthtech companies raised a combined €5.8B across 375 funding rounds, up 60.9% versus H2 2020. UK led by capital raised, and Sofinnova Partners was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| CMR Surgical | Series D+ | Jul 2021 | €505M |
| Sotio Biotech | Other | Dec 2021 | €280M |
| Owkin | Other | Nov 2021 | €159M |
| Sword Health | Series D+ | Nov 2021 |
26 exits · €1.8B disclosed.
| BenevolentAI | IPO | Dec 2021 | €435M |
| Current Health | Acquisition | Nov 2021 | €357M |
| Simbionix | Acquisition | Jul 2021 | €256M |
| Sanifit | Acquisition | Nov 2021 | €205M |
| Bicycle Therapeutics | IPO | Oct 2021 | €173M |
| Zebra Medical Vision | Acquisition | Aug 2021 | €171M |
| €145M |
| DNA Script | Series C | Oct 2021 | €142M |
| Quell Therapeutics | Series B | Nov 2021 | €138M |
| Artios | Series C | Jul 2021 | €130M |
| DentalMonitoring | Other | Oct 2021 | €129M |
| MindMaze | Other | Oct 2021 | €108M |
| Touchlight | Other | Sep 2021 | €107M |
| Anaveon | Series B | Dec 2021 | €105M |
| Pepgen | Other | Aug 2021 | €95M |
| T-knife | Series B | Aug 2021 | €93M |
| bit.bio | Series B | Nov 2021 | €89M |
| Emergence Therapeutics | Other | Dec 2021 | €87M |